US2015079017A1PendingUtilityA1

Perfume Compositions

Assignee: GIVAUDAN NEDERLAND SERVICES G VPriority: Aug 5, 2006Filed: Nov 20, 2014Published: Mar 19, 2015
Est. expiryAug 5, 2026(~0 yrs left)· nominal 20-yr term from priority
A61L 9/01A01K 1/0152A61L 15/46C11B 9/0076C11B 9/0061C11B 9/0034C11B 9/0019C11B 9/0088A61L 15/20C11B 9/0038C11B 9/003C11B 9/0084C11B 9/0015A61L 2300/216
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Perfume compositions comprise between 10% and 30% in total weight of perfume ingredients selected from two groups, Group A, Group B, with the provisos that over 5% but less than 15% of the perfume composition must comprise Group A ingredients, and for compositions comprising less than 10% of Group A ingredients in the aggregate percentage of Group B ingredients present must be at least equal to the expression (2*/10−A %) where A % is the total percentage of Group A ingredients in the composition.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . (canceled) 
     
     
         3 . (canceled) 
     
     
         4 . (canceled) 
     
     
         5 . (canceled) 
     
     
         6 . (canceled) 
     
     
         7 . (canceled) 
     
     
         8 . (canceled) 
     
     
         9 . (canceled) 
     
     
         10 . A method of inhibiting the formation of ammonia from urea, the method comprising the step of:
 contacting urine or urine residues with a perfume composition comprising between 10% and 30% in total by weight of perfume ingredients selected from two groups:   Group A, consisting of:   (3Z)-hex-3-enyl acetate;   3-(1,3-benzodioxol-5-yl)-2-methylpropanal;   (3Z)-hex-3-en-1-ol;   1-[4-(methyloxy)phenyl]ethanone;   3-methyl-5-phenylpentan-1-ol;   5-heptyldihydrofuran-2(3H)-one;   phenylmethyl acetate;   2-(4-methylcyclohex-3-en-1-yl)propan-2-ol;   (3E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one;   (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one;   4-hydroxy-3-(methyloxy)benzaldehyde;   1-methyl-3-(2-methylpropyl)cyclohexanol;   7,9-dimethylspiro[5.5]undecan-3-one;   perfume 1 being LAVANDIN AB8381;   methyl 2,4-dihydroxy-3,6-dimethylbenzoate;   3,7-dimethyloctan-1-ol;   2-(methyloxy)-4-propylphenol;   perfume 2 being ROSENTA AB8428;   1-{[(1R,2S)-2-(1,1-dimethylethyl)cyclohexyl]oxy}butan-2-ol;   perfume 3 being HEADSPACE FREESIA AB7254A;   5-hexyldihydrofuran-2(3H)-one;   prop-2-enyl[(2-methylbutyl)oxy]acetate;   1,3-benzodioxole-5-carbaldehyde;   [4-(1-methylethyl)cyclohexyl]methanol;   2-hexylcyclopent-2-en-1-one;   methyl(2E)-3-phenylprop-2-enoate;   2,6-dimethyloct-7-en-2-ol;   2-methyl-3-[4-(1-methylethyl)phenyl]propanal; and,   Group B consisting of:   2-phenylethanol;   3,7-dimethyloctan-3-ol (tetrahydro linalol), 2-(methyloxy)-4-[(1E)-prop-1-enyl]phenyl acetate;   4-(methyloxy)benzaldehyde;   (2E)-1-(2,6,6-trimethylcyclohex-2-en-1-yl)but-2-en-1-one;   perfume 4 being BERGAMOT AB8392, (3E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one;   cyclopentadecanone; cyclohexadecanolide;   prop-2-enyl 3-cyclohexylpropanoate;   3-[3-(1-methylethyl)phenyl]butanal;   (3Z)-hex-3-enyl methyl carbonate;   (1-methyl-2-{[(1S,3R,5R)-1,2,2-trimethylbicyclo[3.1.0]hex-3-yl]methyl}cyclopropyl)methanol;   [3,3-bis(methyloxy)propyl]benzene;   perfume 5 being COUMAREX I Mod;   tricyclo[5.2.1.0.sup.{2,6}]dec-4-en-8-yl propanoate;   with the provisos that over 5% but less than 15% of the perfume composition must comprise Group A ingredients, and for compositions comprising less than 10% of Group A ingredients, the aggregate percentage of Group B ingredients present must be at least equal to the expression 2*(10−A %) where A % is the total percentage of Group A ingredients in the composition.   
     
     
         11 . The method according to  claim 10 , wherein the perfume composition comprises at least 3 perfume ingredients of Group A. 
     
     
         12 . The method according to  claim 11 , wherein the perfume composition comprises at least 4 perfume ingredients of Group A. 
     
     
         13 . The method according to  claim 12 , wherein the perfume composition comprises at least 6 perfume ingredients of Group A. 
     
     
         14 . The method according to  claim 10 , wherein the perfume ingredients of Group A are selected from the group consisting of:
 (3)-hex-3-enyl acetate;   3-(1,3-benzodioxol-5yl)-2-methylpropanal;   (3Z)-hex-3-en-1-ol;   3-methyl-5-phenylpentan-1-ol;   5-heptyldihydrofuran-2(3H)-one; phenylmethyl acetate;   2-(4-methylcyclohex-3en-1-yl)propan-2-ol;   2,6-dimethyloct-7en-2-ol;   (3E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one;   (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3 en-one;   4-hydoxy-3-(methyloxy)benzaldehyde;   1,3-benzodioxole-5-carbaldehyde.   
     
     
         15 . A method according to  claim 10 , wherein the said perfume composition is incorporated in an article adapted for preventing or ameliorating urine malodour. 
     
     
         16 . A method according to  claim 15 , wherein the said article is a catamenial. 
     
     
         17 . A method according to  claim 15 . wherein the said article is adapted to control incontinence.

Join the waitlist — get patent alerts

Track US2015079017A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.